Merck Wants to Make China Leader in Oncology Treatment

by swisscham in Business

Belen Garijo, president and CEO of German pharmaceutical company Merck Serono SA, has pledged to build the company’s Chinese division into a world leader in oncology treatment, during an interview after a panel discussion at the APEC CEO summit. “We will bring the research to China, develop the compounds, and become a leader in oncology here in the next five to 10 years,” she said. “We have a clear vision in China – by 2020, we will achieve USD1 billion in sales and during this process we will keep bringing new medicines to the country.” Established in Darmstadt, Germany in 1668, Merck operates in 66 countries with 38,000 employees. Merck Serono is its bio-pharmaceutical division and specializes in treating prevalent chronic conditions such as cancer and metabolic diseases.

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Your Swiss Business Platform in China

SwissCham China has roughly 600 company members. Our Chamber maintains a strong relationship with the Embassy of Switzerland, Swiss Global Enterprise, Swissnex and Switzerland Tourism. As the representative of the Swiss companies established in China, our goal is to help you to increase your business and visibility, especially amongst the Sino-Swiss business community.

Become A Member

Sign Up For Our Newsletter

  • This field is for validation purposes and should be left unchanged.
October 9, 2020
Published By chinadaily.com.cn in Engineering / Manufacturing
October 6, 2020
Published By globenewswire.com in Engineering / Manufacturing
September 24, 2020
Published By schindler.com in Engineering / Manufacturing
September 14, 2020
Published By cgtn.com in Bilateral Relations
September 3, 2020
Published By s-ge.com in General Interest